Form 4 for ISRG Intuitive Surgical
Accepted 2023-04-24 00:00:00 ET · period of report 2023-04-21 · accession 0001035267-23-000099 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-04-24 | 2023-04-21 | ISRG | DeSantis Robert | EVP, Chief Product Off | S - Sale+OE | $297.92 | -8,623 | 9,428 | -48% | -$2.57M |
| DM | 2023-04-24 | 2023-04-21 | ISRG | DeSantis Robert | EVP, Chief Product Off | M - OptEx | $224.88 | +6,260 | 10.5K | +147% | +$1.41M |
| DM | 2023-04-24 | 2023-04-21 | ISRG | DeSantis Robert | EVP, Chief Product Off | M - OptEx | $0.00 | -6,260 | 996 | -86% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-21 | S | D | 273 | $298.00 | 9,428 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.61 to $299.31 as follows: 116 shares sold at $296.61 to $297.00; 370 shares sold at $297.78 to $298.74; and 60 shares sold at $298.99 to $299.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-04-21 | M | A | 273 | $177.99 | 9,701 | D | — | — | |
| 3 | Common | Common Stock | 2023-04-21 | S | D | 273 | $298.00 | 9,428 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.61 to $299.31 as follows: 116 shares sold at $296.61 to $297.00; 370 shares sold at $297.78 to $298.74; and 60 shares sold at $298.99 to $299.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2023-04-21 | M | A | 273 | $179.70 | 9,701 | D | — | — | |
| 5 | Common | Common Stock | 2023-04-21 | S | D | 1,086 | $297.92 | 9,428 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.55 to $299.16 as follows: 656 shares sold at $296.55 to $297.55; 1.979 shares sold at $297.56 to $298.53; and 635 shares sold at $298.62 to $299.16. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2023-04-21 | S | D | 2,184 | $297.92 | 9,428 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.55 to $299.16 as follows: 656 shares sold at $296.55 to $297.55; 1.979 shares sold at $297.56 to $298.53; and 635 shares sold at $298.62 to $299.16. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2023-04-21 | M | A | 2,184 | $245.60 | 11,612 | D | — | — | |
| 8 | Common | Common Stock | 2023-04-21 | S | D | 1,167 | $297.90 | 7,065 | D | — | — | (F6) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.39 to $299.22 as follows: 216 shares sold at $296.39 to $297.12; 705 shares sold at $297.42 to $298.41; and 246 shares sold at $298.50 to $299.22. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 9 | Common | Common Stock | 2023-04-21 | S | D | 1,196 | $297.91 | 8,232 | D | — | — | (F5) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.59 to $299.27 as follows: 271 shares sold at $296.59 to $297.41; 725 shares sold at $297.66 to $298.62; and 200 shares sold at $298.68 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2023-04-21 | S | D | 2,444 | $297.93 | 9,428 | D | — | — | (F4) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.52 to $299.30 as follows: 612 shares sold at $296.52 to $297.52; 1.413 shares sold at $297.57 to $298.50; and 419 shares sold at $298.63 to $299.30. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 11 | Common | Common Stock | 2023-04-21 | M | A | 2,444 | $208.90 | 11,872 | D | — | — | |
| 12 | Common | Common Stock | 2023-04-21 | M | A | 1,086 | $242.34 | 10,514 | D | — | — | |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-04-21 | M | D | 2,184 | $0.00 | 4,566 | D | $245.60 · — to 2031-02-26 | 2,184 Common Stock | (F7) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-04-21 | M | D | 1,086 | $0.00 | 996 | D | $242.34 · — to 2030-08-28 | 1,086 Common Stock | (F9) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 15 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-04-21 | M | D | 2,444 | $0.00 | 6,579 | D | $208.90 · — to 2029-08-28 | 2,444 Common Stock | (F9) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 16 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-04-21 | M | D | 273 | $0.00 | 1,176 | D | $179.70 · — to 2030-05-11 | 273 Common Stock | (F8) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. |
| 17 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-04-21 | M | D | 273 | $0.00 | 996 | D | $177.99 · — to 2030-02-28 | 273 Common Stock | (F7) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |